These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15296275)

  • 1. [Chemoprophylaxis and vaccine for prevention of bacterial meningitis in children].
    Bourrillon A; Bingen E
    Rev Prat; 2004 May; 54(9):973-8. PubMed ID: 15296275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
    Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
    Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningococcal infections: aspects of microbiology, epidemiology and prevention].
    Ehrhard I; Sonntag HG
    Gesundheitswesen; 1999 Oct; 61 Spec No 1():S41-5. PubMed ID: 10593044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of meningococcal disease.
    Kimmel SR
    Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
    Prasad K; Karlupia N
    Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implications of vaccines for prevention of bacterial meningitis.
    Riordan A
    Curr Opin Neurol; 2010 Jun; 23(3):319-24. PubMed ID: 20173637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal vaccines.
    Collins CL; Pollard AJ
    Curr Opin Investig Drugs; 2002 Jul; 3(7):975-9. PubMed ID: 12186274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute bacterial meningitis among children < 5 years of age in Oman: a retrospective study during 2000-2005.
    Dash N; Panigrahi D; Al Khusaiby S; Al Awaidy S; Bawikar S
    J Infect Dev Ctries; 2008 Apr; 2(2):112-5. PubMed ID: 19738334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of meningococcal meningitis in children in France].
    Levy C; Taha MK; Weill Olivier C; Quinet B; Lécuyer A; Alonso JM; Cohen R; Bingen E;
    Arch Pediatr; 2008 Dec; 15 Suppl 3():S105-10. PubMed ID: 19268239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years.
    Renner LA; Newman MJ; Ahadzie L; Antwi-Agyei KO; Eshetu M
    Pediatr Infect Dis J; 2007 Apr; 26(4):356-8. PubMed ID: 17414404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of vaccine research and development: meningococcal disease.
    Girard MP; Preziosi MP; Aguado MT; Kieny MP
    Vaccine; 2006 May; 24(22):4692-700. PubMed ID: 16621189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
    Nigrovic LE; Kuppermann N; Malley R;
    Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.